Dr. Chomas is widely acknowledged as a skilled leader of people, a translator of strategy into actionable and quantitative plans, and an inventor of intellectual property who is effective at building high performing leadership teams and working with boards of directors. His experience in identifying innovative solutions with strong profit potential, developing new markets, and organizing investors to maximize impact will be of immediate benefit to CereHealth as it positions itself to optimize market opportunities for its proprietary technologies.
About CereHealth
CereHealth is a technology company that provides Medical Analytics as a Service (MAaaS), enabling doctors, research scientists and healthcare experts to apply Precision Medicine and individualized patient care to their practice with pinpoint accuracy.
CereHealth has two novel data analytics platforms:
CereMetrixAiâ„¢, a leader in quantitative imaging analysis and biomarkers for central nervous system disorders, , and iLLUMEAi, which utilizes graph technology to create correlations among complex medical datasets using high-performance computing for advanced multivariable analysis.
SOURCE CereHealth Corp
Back to HCB News